Personalized Medicine in the Field of Inflammatory Skin Disorders

Skin inflammation is associated with a wide range of conditions which represent major health issues worldwide. Skin and mucosal surfaces represent the primary interface between the human body and the environment, susceptible to numerous factors whose action results in diseases produced by chemical s...

Full description

Saved in:
Bibliographic Details
Other Authors: Tampa, Mircea (Editor), Neagu, Monica (Editor), Caruntu, Constantin (Editor), Georgescu, Simona Roxana (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_81151
005 20220506
003 oapen
006 m o d
007 cr|mn|---annan
008 20220506s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-3573-9 
020 |a 9783036535746 
020 |a 9783036535739 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-3573-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Tampa, Mircea  |4 edt 
700 1 |a Neagu, Monica  |4 edt 
700 1 |a Caruntu, Constantin  |4 edt 
700 1 |a Georgescu, Simona Roxana  |4 edt 
700 1 |a Tampa, Mircea  |4 oth 
700 1 |a Neagu, Monica  |4 oth 
700 1 |a Caruntu, Constantin  |4 oth 
700 1 |a Georgescu, Simona Roxana  |4 oth 
245 1 0 |a Personalized Medicine in the Field of Inflammatory Skin Disorders 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (262 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Skin inflammation is associated with a wide range of conditions which represent major health issues worldwide. Skin and mucosal surfaces represent the primary interface between the human body and the environment, susceptible to numerous factors whose action results in diseases produced by chemical substances, mechanical trauma, microbial agents, radiation, etc. Inflammation, a complex network of interactions between soluble molecules and cells, represents the main modality of the skin's response to injuries. Numerous studies have revealed close links between chronic inflammation, oxidative stress, and carcinogenesis. Chronic inflammation induces the activation of various cell types and an increase in the production of reactive oxygen species, promoting the initiation of a malignant process. Identifying specific biomarkers is essential for understanding molecular mechanisms and developing therapies appropriate to the patient's characteristics.Personalized medicine is an emerging field of medicine that has the potential to predict which therapy will be safe and efficacious for specific patients using an individual's genetic profile to guide decisions regarding the diagnosis, treatment, as well as prevention of disease. This book gathers articles that present recent advancements in research involving the mechanisms that underlie the development of inflammatory skin disorders, skin and mucosal inflammation in general. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a sea-buckthorn seed oil 
653 |a long-chain fatty acids 
653 |a skin dysplastic keratinocytes 
653 |a UVA 
653 |a CD36 
653 |a SR-B2 
653 |a atopic dermatitis 
653 |a eczema 
653 |a JAK inhibitors 
653 |a systematic review 
653 |a meta-analysis 
653 |a evidence-based medicine 
653 |a immune-mediated skin diseases 
653 |a target therapy 
653 |a skin conditions and systemic inflammatory diseases 
653 |a systemic sclerosis 
653 |a biomarker 
653 |a calumenin 
653 |a S100A6 
653 |a cytohesin 2 
653 |a cannabinoids 
653 |a inflammation 
653 |a gut-lung-skin barrier 
653 |a signaling pathways 
653 |a inflammatory biomarkers 
653 |a psoriasis vulgaris 
653 |a prevalence 
653 |a comorbidities 
653 |a risk factors 
653 |a systemic lupus erythematous 
653 |a lupus nephritis 
653 |a lipid peroxidation 
653 |a DNA oxidation 
653 |a oxidized proteins 
653 |a carbohydrate oxidation 
653 |a antioxidative stress strategies 
653 |a biomarkers 
653 |a IgY 
653 |a psoriatic dermatitis 
653 |a imiquimod 
653 |a C57 BL/6 mice 
653 |a alginate 
653 |a biomaterial 
653 |a dressing 
653 |a fibers 
653 |a hydrogel 
653 |a nanofibers 
653 |a commercially available 
653 |a wound care 
653 |a wound healing 
653 |a cutaneous melanoma 
653 |a epigenetic regulation 
653 |a drug resistance 
653 |a therapeutic targets 
653 |a epigenetic therapy 
653 |a immune response 
653 |a Sutton nevi 
653 |a halo nevi 
653 |a skin tumor 
653 |a psoriasis 
653 |a proteome analysis 
653 |a estrogen 
653 |a menopause 
653 |a cSCC 
653 |a AK 
653 |a sialylation 
653 |a sialyltransferase 
653 |a sialidase 
653 |a COVID-19 
653 |a pyoderma gangrenosum 
653 |a immunosuppression 
653 |a cyclosporine 
653 |a corticosteroids 
653 |a autoinflammatory disease 
653 |a androgenic alopecia 
653 |a clinical trial 
653 |a hair density 
653 |a platelet-rich plasma 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/5182  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/81151  |7 0  |z DOAB: description of the publication